Ledger.Open graph →
SEC Form D · Amendment · filed February 22, 2024

Areteia Therapeutics, Inc

Offering
$445.0M
Sold
$275.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHAPEL HILL, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Robin E. Walker · Chapel Hill, NCExecStephen E. Butts · Chapel Hill, NCDirectorDaniel N. Caruso · Cremorne, Channel IslandsDirectorStephen E. Butts · Chapel Hill, NCDirectorBenjamin Gomez · Chapel Hill, NCDirectorJorge E. Bartolome · Chapel Hill, NCExec · DirectorAdam Koppel · Chapel Hill, NCDirectorElyse E. Stock · Chapel Hill, NCDirectorAdam Koppel · Chapel Hill, NCDirectorSusan N. Collas · Cremorne, Channel IslandsDirectorBenjamin Gomez · Chapel Hill, NCDirectorJackson N. Zeng · Cremorne, Channel IslandsExec · DirectorDaniel E. Becker · Chapel Hill, NCDirectorMathew Ray · Concord, MADirectorChristopher E. Courts · Chapel Hill, NCExecTommy N. Rogulj · Cremorne, Channel IslandsDirectorLuke Schofield · Cremorne, Channel IslandsDirectorPaul Berns · Chapel Hill, NCDirectorPaul Berns · Chapel Hill, NCDirectorJohn Dorman · Concord, MADirectorMichael E. Bozik · Chapel Hill, NCDirectorRobin E. Walker · Chapel Hill, NCExecEric Voogt · Denver, CODirectorIan Read · Chapel Hill, NCDirectorDaniel E. Becker · Chapel Hill, NCDirectorChristopher E. Courts · Chapel Hill, NCExecZach Posner · Denver, CODirectorElyse E. Stock · Chapel Hill, NCDirectorMichael E. Bozik · Chapel Hill, NCDirectorIan Read · Chapel Hill, NCDirectorJorge E. Bartolome · Chapel Hill, NCExec · DirectorJames Brown · Denver, COExecMark Kreloff · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗